1. Home
  2. IKT vs PCQ Comparison

IKT vs PCQ Comparison

Compare IKT & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • PCQ
  • Stock Information
  • Founded
  • IKT 2008
  • PCQ 2001
  • Country
  • IKT United States
  • PCQ United States
  • Employees
  • IKT N/A
  • PCQ N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • PCQ Investment Managers
  • Sector
  • IKT Health Care
  • PCQ Finance
  • Exchange
  • IKT Nasdaq
  • PCQ Nasdaq
  • Market Cap
  • IKT 159.2M
  • PCQ 180.1M
  • IPO Year
  • IKT 2020
  • PCQ N/A
  • Fundamental
  • Price
  • IKT $2.31
  • PCQ $9.49
  • Analyst Decision
  • IKT Strong Buy
  • PCQ
  • Analyst Count
  • IKT 2
  • PCQ 0
  • Target Price
  • IKT $6.50
  • PCQ N/A
  • AVG Volume (30 Days)
  • IKT 310.9K
  • PCQ 69.6K
  • Earning Date
  • IKT 11-14-2024
  • PCQ 01-01-0001
  • Dividend Yield
  • IKT N/A
  • PCQ 4.63%
  • EPS Growth
  • IKT N/A
  • PCQ N/A
  • EPS
  • IKT N/A
  • PCQ N/A
  • Revenue
  • IKT $1.00
  • PCQ N/A
  • Revenue This Year
  • IKT N/A
  • PCQ N/A
  • Revenue Next Year
  • IKT N/A
  • PCQ N/A
  • P/E Ratio
  • IKT N/A
  • PCQ N/A
  • Revenue Growth
  • IKT N/A
  • PCQ N/A
  • 52 Week Low
  • IKT $0.85
  • PCQ $8.19
  • 52 Week High
  • IKT $3.82
  • PCQ $10.50
  • Technical
  • Relative Strength Index (RSI)
  • IKT 52.09
  • PCQ 31.43
  • Support Level
  • IKT $1.75
  • PCQ $9.42
  • Resistance Level
  • IKT $2.10
  • PCQ $9.93
  • Average True Range (ATR)
  • IKT 0.33
  • PCQ 0.12
  • MACD
  • IKT -0.10
  • PCQ -0.03
  • Stochastic Oscillator
  • IKT 28.87
  • PCQ 13.73

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.

Share on Social Networks: